摘要
近年来,我国2型糖尿病的发病率不断上升,由此引发的各种慢性微血管并发症也在增多,糖尿病肾病是糖尿病最常见的微血管并发症,也是终末期肾功能衰竭的主要原因。糖尿病肾病的确切发病机制不明,蛋白尿是最常见的临床表现,最近有研究认为肾小管功能紊乱在糖尿病肾病蛋白尿的形成中发挥着重要作用,
出处
《中华检验医学杂志》
CAS
CSCD
北大核心
2011年第12期1081-1083,共3页
Chinese Journal of Laboratory Medicine
基金
广东省东莞市科技局重点课题资助项目(200910515000104)
参考文献15
-
1Russo LM,Sandoval RM,McKeeM,et al.The normal kidney filtersnephrotic levels of albumin retrieved by proximal tubule cells:retrieval is disrupted in nephrotic states.Kidney Int,2007,71:504-513.
-
2Russo LM,Osicka TM,Brammar GC,et al.Renal processing of albumin in diabetes and hypertension in rats. Am J Nephrol,2003,23:61-70.
-
3Devarajan P. Neutrophil gelatinase-associated lipocalin-an emerging troponin for kidney injury. Nephrol Dial Transplant,2008,23:3737-3743.
-
4Bolignano D, Donato V, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage.Am J Kidney Dis,2008,52:595-605.
-
5Macisaac RJ,Tsalamandris C,Thomas MC,et al. Estimating glomerularfiltration rate in diabetes:a comparison of cystatin-C and creatinine-based methods.Diabetologia,2006,49:1686-1689.
-
6Jerums G,Panagiotopoulos S,Premaratne E,et al. Integrating albuminuria and GFR in the assessment of diabetic nephropathy.Nat Rev Nephrol,2009,5:397-406.
-
7孙延生,庄严,贺松.尿微量白蛋白、α_1-微球蛋白、NAG检测对糖尿病肾病早期诊断的探讨[J].交通医学,2008,22(1):42-42. 被引量:7
-
8Vaidya VS, Niewczas MA, Ficociello LH. Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers,kidney injury molecule-1,and N-acetyl-β-D-glucosaminidase.Kidney Int,2011,79:464-470.
-
9Kuwabara T,Mori K,Mukoyama M,et al. Urinary neutrophil gelatinase-associated lipocalin levels reflect damage to glomeruli,proximal tubules,and distal nephrons. Kidney Int,2009,75:285-294.
-
10Suzuki M,Wiers KM,Klein-Gitelman MS,et al. Neutrophil elatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis.Pediatr Nephrol,2008,23:403-412.
二级参考文献40
-
1Bolignano D, Donato V, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) as a marker of kidney damage [ J]. Am J Kidney Dis, 2008, 52 (3): 595-605.
-
2Donadio C, Luehesi A. Serum eystatin as a marker of glomerular filtration rate [J]. Am J Kidney Dis, 2001, 37 (2) : 448 -451.
-
3Devarajan P. Emerging biomarkers of acutekidney injury [J]. Contrib Nephrol, 2007, 156:203 -212.
-
4Mitsnefes MM, Kathman TS, Mishra J, et al. Serum neutrophil gelatinase - associated lipocalin as a marker of renal function in childrenwith chronic kidney disease[J].Pediatr Nephrol, 2007, 22:101 -108.
-
5Mori K, Lee HT, Rapoport D, et al. Endoeytie delivery of lipoealin - siderophore - iron complex rescues the kidney from isehemia - reperfusion injury [J]. J Clin Invest, 2005, 115 (3) : 610 -621.
-
6Mishra J, Dent C, Tarabishi R, et al. Neutrophilgelatinase - associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery[J]. Lancet, 2005, 365:1231-1238.
-
7Laterza OF, Price CP, Scott MG. Cystatin C: an improved estimator of glomerular filtration rate [ J]. Clinical Chemistry, 2002, 48 (12) : 699 - 707.
-
8Risch L, Huber AR. Assessing the diagnostic accuracy of eystatin C as a marker of impaired glomerular filtration rate [ J ]. Am J Kidney Dis, 2002, 39:661-662.
-
9Kellum JA, Levin N, Bouman C, et al. Developing a consensus classification system for acute renal failure. Curr Opin Crit Care,2002, 8:509-514.
-
10Bellomo R, Angus D, Star RA. The acute dialysis quality initiative, pan Ⅱ :patient selection for CRRT. Adv Ren Replace Ther, 2002,9:255-259.
共引文献69
-
1刘津,李海平,马淑慧.中性粒细胞明胶酶脂质运载蛋白(NGAL)检测的临床应用[J].医学信息(医学与计算机应用),2014,0(22):675-675.
-
2Abudula.Reziwanguli,Xue Song.Effects of Irbesartan combined Atorvastatin on serum levels of Cys C, Hcy, TNF-α, ET, TGF-b1 in patients with early diabetic nephropathyn[J].Journal of Hainan Medical University,2017,23(20):35-38.
-
3倪亚丽.尿微量白蛋白测定对早期糖尿病肾病的诊断意义[J].交通医学,2010,24(1):89-89. 被引量:5
-
4杨小东.尿微量白蛋白测定在早期糖尿病肾病中的应用[J].中国医药导报,2011,8(4):36-37. 被引量:10
-
5赵璇,郭常辉,张晓娟,晏丕军.2型糖尿病患者血清NGAL水平与早期糖尿病肾病的关系[J].医学信息(中旬刊),2011,24(4):1258-1260. 被引量:1
-
6邱彬,杨云勇.半胱氨酸蛋白酶抑制剂C在肾功能损害早期诊断中的应用[J].中国基层医药,2011,18(9):1210-1211. 被引量:1
-
7王玉新,赵晓云.新型急性肾损伤早期的标志物NGAL研究现状[J].中国误诊学杂志,2011,11(15):3557-3558. 被引量:1
-
8张军能,方跃亭.尿微量白蛋白在糖尿病肾病的诊断价值分析[J].中国医药指南,2011,9(17):245-246. 被引量:1
-
9杨生,郭洵.西洛他唑和缬沙坦联合治疗对早期糖尿病肾病患者血清胱抑素C和脂联素的影响[J].中国老年学杂志,2011,31(12):2188-2190. 被引量:5
-
10顾琰颖,郑瑶.糖化血红蛋白、尿微量清蛋白联合测定对糖尿病肾病的诊断价值[J].中国基层医药,2011,18(21):2963-2964. 被引量:4
同被引文献83
-
1吴敏,丁建华,李建东,王传晶.肾病患者血清荧光光谱分析初探[J].激光杂志,2005,26(2):83-84. 被引量:2
-
2韩媛,黄松明,张维真,鲍华英,吴红梅.儿童免疫球蛋白A肾病临床与病理分析[J].实用儿科临床杂志,2006,21(5):284-285. 被引量:4
-
3曹友德,李朝晖,李浩.糖尿病早期肾损伤患者尿视黄醇结合蛋白检测的临床意义[J].中国医学工程,2006,14(1):11-13. 被引量:10
-
4王战建,苏杰英.以循证医学为依据建立科学的糖尿病筛查和诊断标准──读IDF 2005全球2型糖尿病指南(一)[J].临床荟萃,2006,21(10):760-760. 被引量:25
-
5闻平,陈蕾,郭月芳,周春红.晨尿尿蛋白/尿渗透压比值测定的临床应用评价[J].国际检验医学杂志,2006,27(9):777-778. 被引量:11
-
6杨霓芝,刘旭生.糖尿病肾病诊断、辨证分型及疗效评定标准(试行方案)[J].上海中医药杂志,2007,41(7):7-8. 被引量:1310
-
7马斌荣.医学统计学[M].第5版.北京:人民卫生出版社,1999:10—15.
-
8Yang YH,He XJ, Chen SR,et al. Changes of serumand urine neutrophil gelatinase-associated lipocalin intype-2 diabetic patients with nephropathy : one year obser-vational follow-up study[J]. Endocrine. 2009,36(1):45-51.'.
-
9Clerico A,Galli C,Fortunato A,et al. Neutrophil gela-tinase-associated lipocalin (NGAL) as biomarker of acutekidney injury: a review of the laboratory characteristicsand clinical evidences [J]. Clin Chem Lab Med. 2012,50(9):1505-1517.
-
10Sargentini V,Mariani P,D; Alessandro M, et al. As-sessment of NGAL as an early biomarker of acute kidneyinjury in adult cardiac surgery patients [J], J Biol Regul. Homeost Agents, 2012,26(3) :485-493.
引证文献13
-
1郑玉梅.糖尿病肾病与尿微量白蛋白的关系[J].中国社区医师(医学专业),2012,14(17):118-118. 被引量:5
-
2周丽杰.尿视黄醇结合蛋白与N-乙酰-β-D-氨基葡萄糖苷酶在判断糖尿病及高血压早期肾损伤中的临床意义[J].中国民康医学,2013,25(6):30-30. 被引量:6
-
3周晓萍.IgA肾病患者尿NGAL和免疫球蛋白轻链的水平及临床意义[J].重庆医学,2013,42(12):1399-1401. 被引量:4
-
4李俊如,黄静.血清视黄醇结合蛋白(RBPs)和尿N-乙酰-β-D氨基葡萄糖苷酶(NAG)在糖尿病肾病诊断中的价值[J].成都医学院学报,2013,8(6):706-708. 被引量:10
-
5刘丽,张会芬,杨宏秀,袁宝军,刘鑫.2型糖尿病肾病患者eGFR、尿NAG和血清NGAL水平及意义[J].中国临床医生杂志,2019,47(1):52-55. 被引量:19
-
6王冬梅,袁少伟,丁莉.血和尿NGAL指标检测在糖尿病肾病诊断中的价值[J].宁夏医学杂志,2014,36(9):809-811. 被引量:3
-
7黄声淳,张劲丰,谢小梅,陈玉祯,陈家钖.2型糖尿病患者的血、尿渗透压检测对糖尿病肾病的早期诊断[J].医学理论与实践,2016,29(7):941-943. 被引量:1
-
8董喜环.血清NGAL、CysC、RBP及MMP-2联合检测对糖尿病肾病的诊断价值[J].国际检验医学杂志,2016,37(14):1965-1967. 被引量:17
-
9杨宏秀,张会芬,刘丽,袁宝军,高利常.血清NGAL、TRF、hs-CRP及SF在糖尿病肾病诊断中的价值[J].山东医药,2017,57(46):50-52. 被引量:28
-
10王姗姗,徐晓东,楼雪勇.早期糖尿病肾病的发生发展与尿KIM-1、NGAL相关性的随访研究[J].中国现代医生,2019,57(5):5-8. 被引量:7
二级引证文献111
-
1马统雄.尿蛋白和尿微量白蛋白在糖尿病肾病检验中的应用效果研究[J].智慧健康,2021,7(35):12-15. 被引量:8
-
2刘运双,张彬,张亚梅,罗立梅,邓蔷.血清NGAL对早期诊断2型糖尿病肾病的临床价值[J].热带医学杂志,2020,20(1):97-101. 被引量:5
-
3海江,刘芳.参芪地黄汤加味治疗气阴两虚兼血瘀证糖尿病肾病临床疗效及对尿KIM-1、L-FABP影响[J].辽宁中医药大学学报,2021,23(11):163-166. 被引量:19
-
4高灿灿,范培云,樊海宁.血清VitD、尿NAG与2型糖尿病合并DKD的相关研究进展[J].世界最新医学信息文摘,2021(15):196-197.
-
5刘津,李海平,马淑慧.中性粒细胞明胶酶脂质运载蛋白(NGAL)检测的临床应用[J].医学信息(医学与计算机应用),2014,0(22):675-675.
-
6王淑琴,王建勇,陈永谦,满洁.2型糖尿病肾病患者血清胱抑素C水平检测的临床价值[J].中国实用医药,2012,7(35):25-26. 被引量:2
-
7郑红.糖尿病肾病患者尿微量白蛋白检测的临床意义[J].海南医学,2013,24(13):1958-1960. 被引量:21
-
8李俊如,黄静.血清视黄醇结合蛋白(RBPs)和尿N-乙酰-β-D氨基葡萄糖苷酶(NAG)在糖尿病肾病诊断中的价值[J].成都医学院学报,2013,8(6):706-708. 被引量:10
-
9纪官治.尿微量白蛋白和尿α1-微球蛋白、尿转铁蛋白对糖尿病肾病早诊断的意义[J].现代诊断与治疗,2013,24(15):3472-3473.
-
10黄光豪,曾华美.尿微量清蛋白检测对诊断早期糖尿病肾病的临床意义[J].检验医学与临床,2014,11(14):1907-1908. 被引量:7
-
1王月娥.糖尿病肾病患者的护理对策[J].中国现代医生,2009,47(21):138-139. 被引量:13
-
2王莺,孔梅,张晓霞.162例2型糖尿病肾病的护理干预[J].中国临床实用医学,2010,4(4):242-243. 被引量:3
-
3谷源平,孟庆辉.自拟芪蛭汤治疗糖尿病肾病[J].中国中医药现代远程教育,2005,3(5):43-43.
-
4陈勇.黄葵胶囊联合替米沙坦治疗糖尿病肾病的临床研究(附52例报告)[J].咸宁学院学报(医学版),2010,24(5):411-412. 被引量:3
-
5张焱生.中西医结合治疗糖尿病肾病30例的临床观察[J].临床和实验医学杂志,2006,5(4):402-403. 被引量:1
-
6那开宪.血液透析患者的高血压问题[J].中国医刊,2011,46(1):90-91. 被引量:5
-
7王红霞.贝那普利联合缬沙坦治疗糖尿病肾病疗效观察[J].实用医技杂志,2010,17(10):962-963. 被引量:6
-
8李孟建.洛汀新联合黄芪治疗早期糖尿病肾病临床疗效观察[J].山西医药杂志(下半月),2010,39(4):359-360.
-
9鲁新红,王松,汪涛.糖尿病肾病饮食治疗指南[J].糖尿病新世界,2009(3):40-42. 被引量:2
-
10鲁新红,王松,汪涛.糖尿病肾病饮食治疗[J].糖尿病新世界,2013(10):46-49. 被引量:1